The global 3D bio-printing market is poised for significant expansion, with projections indicating a rise from an ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 70.45% ...

Fourth-quarter revenue of $0.73 million, up 64% year-over-year –- Full-year revenue of $3.11 million, up 148% year-over-year –- As of June 30, ...

Instil Bio Inc (TIL) stock saw a modest uptick, ending the day at $66.1 which represents a slight increase of $1.31 or 2.02% from the prior close of $64.79. The stock opened at $64.75 and touched a ...

PHILADELPHIA, PA — Passage Bio, Inc. has unveiled promising interim data from its ongoing global Phase 1/2 upliFT-D clinical ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Upstream Bio, Inc. has filed for an Initial Public Offering (IPO) and seeks to list its common stock on the Nasdaq Global Market under the symbol 'UPB'. Leading financial institutions J.P. Morgan, TD ...

Custom MIPSA antigen libraries can also be created to address specific research needs. About Infinity Bio Infinity Bio, Inc.

A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...